セッション詳細
[K1]Kick-off Meeting for the MCM Program 1
2026年7月8日(水) 13:40 〜 14:29
伊藤謝恩ホール(伊藤国際学術研究センターB2)
座長:山本 瑞生、小林 穂高
[K1-01]アカデミア創薬推進における課題と解決策
*Tatsuya Zenkoh1 (1. The UTOPIA Center, The University of Tokyo (Japan))
[K1-02]Human B cell responses in vaccination and autoimmune disease
*Takeshi Inoue1 (1. The UTOPIA Center, The University of Tokyo (Japan))
[K1-03]Fc領域を持たない抗体のmRNAを用いた緑膿菌治療
*Satoshi Uchida1 (1. Department of Advanced Nanomedical Engineering, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (Japan))
[K1-04]膜融合アッセイによるSARS-CoV-2侵入阻害剤の探索
*Mizuki Yamamoto1, Yoko Hirayama1, Jun-ichiro Inoue2, Yasushi Kawaguchi3,1,2, Xuenan Xuan1 (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan), 2. The University of Tokyo Pandemic preparedness, Infection and Advanced research center (UTOPIA), The University of Tokyo (Japan), 3. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan))
[K1-05]A platform to monitor mRNA vaccine function with single-molecule imaging
*Hotaka Kobayashi1,2 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan))
[K1-06]ヘニパウイルスワクチン開発に向けたパラミクソウイルスベースプラットフォーム
*YUYING WANG1, Taishi Onodera2, Yuki Kitai1, Yukiko Akahori1, Hekai Yang1, Hiroshi Katoh1, Akihide Ryo2, Katsumi Maenaka3, Takao Hashiguchi4, Junki Maruyama5, Yoshimasa Takahashi2, Makoto Takeda1 (1. The University of Tokyo (Japan), 2. Japan Institute for Health Security, National Institute of Infectious Diseases (Japan), 3. Hokkaido University (Japan), 4. Kyoto University (Japan), 5. University of Texas Medical Branch (USA))
[K1-07]改変ウイルス産生システムを用いたハイスループットスクリーニング系の開発
*Kio Horinaka1, Osamu Nureki1, Feng Zhang2 (1. Department of Biological Science, Faculty of Science, The University of Tokyo (Japan), 2. Broad Institute of MIT and Harvard (USA))